Literature DB >> 21041720

CIITA enhances HIV-1 attachment to CD4+ T cells leading to enhanced infection and cell depletion.

Kristen A Porter1, Lauren N Kelley, Michael D Nekorchuk, James H Jones, Amy B Hahn, Carlos M C de Noronha, Jonathan A Harton, Karen M Duus.   

Abstract

Activated CD4(+) T cells are more susceptible to HIV infection than resting T cells; the reason for this remains unresolved. Induction of CIITA and subsequent expression of the MHC class II isotype HLA-DR are hallmarks of CD4(+) T cell activation; therefore, we investigated the role of CIITA expression in T cells during HIV infection. CIITA-expressing SupT1 cells display enhanced virion attachment in a gp160/CD4-dependent manner, which results in increased HIV infection, virus release, and T cell depletion. Although increased attachment and infection of T cells correlated with HLA-DR surface expression, Ab blocking, transient expression of HLA-DR without CIITA, and short hairpin RNA knockdown demonstrate that HLA-DR does not directly enhance susceptibility of CIITA-expressing cells to HIV infection. Further analysis of the remaining MHC class II isotypes, HLA-DP and HLA-DQ, MHC class I isotypes, HLA-A, HLA-B, and HLA-C, and the class II Ag presentation genes, invariant chain and HLA-DM, demonstrate that these proteins likely do not contribute to CIITA enhancement of HIV infection. Finally, we demonstrate that in activated primary CD4(+) T cells as HLA-DR/CIITA expression increases there is a corresponding increase in virion attachment. Overall, this work suggests that induction of CIITA expression upon CD4(+) T cell activation contributes to enhanced attachment, infection, virus release, and cell death through an undefined CIITA transcription product that may serve as a new antiviral target.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21041720     DOI: 10.4049/jimmunol.1000830

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial.

Authors:  Melanie A Gasper; Anneke C Hesseling; Isaac Mohar; Landon Myer; Tali Azenkot; Jo-Ann S Passmore; Willem Hanekom; Mark F Cotton; I Nicholas Crispe; Donald L Sodora; Heather B Jaspan
Journal:  JCI Insight       Date:  2017-04-06

2.  Differential transmembrane domain GXXXG motif pairing impacts major histocompatibility complex (MHC) class II structure.

Authors:  Ann M Dixon; Lisa Drake; Kelly T Hughes; Elizabeth Sargent; Danielle Hunt; Jonathan A Harton; James R Drake
Journal:  J Biol Chem       Date:  2014-03-11       Impact factor: 5.157

3.  HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of Islet β-Cells From Donors With Type 1 Diabetes.

Authors:  Mark A Russell; Sambra D Redick; David M Blodgett; Sarah J Richardson; Pia Leete; Lars Krogvold; Knut Dahl-Jørgensen; Rita Bottino; Marcela Brissova; Jason M Spaeth; Jenny Aurielle B Babon; Rachana Haliyur; Alvin C Powers; Chaoxing Yang; Sally C Kent; Alan G Derr; Alper Kucukural; Manuel G Garber; Noel G Morgan; David M Harlan
Journal:  Diabetes       Date:  2019-03-04       Impact factor: 9.461

4.  Evaluation of a method to measure HHV-6B infection in vitro based on cell size.

Authors:  Aniuska Becerra-Artiles; Tessa Santoro; Lawrence J Stern
Journal:  Virol J       Date:  2018-01-05       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.